Multiple sclerosis patients initiating ofatumumab in the real-world: 6 months data

被引：0
|
作者：
Coyle, P. [1 ]
Gorritz, M. [2 ]
Wade, R. [2 ]
Zhou, Z. [2 ]
Cao, Y. [2 ]
Deshpande, C. [3 ]
机构：
[1] SUNY Stony Brook, Dept Neurol, Stony Brook, NY 11794 USA
[2] IQVIA, Plymouth Meeting, PA USA
[3] Novartis Pharmaceut, E Hanover, NJ USA
来源：
MULTIPLE SCLEROSIS JOURNAL | 2021年 / 27卷 / 2_SUPPL期
关键词：
D O I：
暂无
中图分类号：
R74 [神经病学与精神病学];
学科分类号：
摘要：
P874
引用
收藏
页码：715 / 716
页数：2
相关论文
共 50 条
  • [1] Ofatumumab and Early Immunological Cells Subset Characterization in Naive Relapsing Multiple Sclerosis Patients: A Real-World Study
    D'Amico, Emanuele
    Zanghi, Aurora
    Fantozzi, Roberta
    Centonze, Diego
    Avolio, Carlo
    [J]. CURRENT NEUROPHARMACOLOGY, 2023, 21 (12) : 2563 - 2566
  • [2] Real-World Experience with Ofatumumab
    Thomas, K.
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 202 - 203
  • [3] A Multicenter Real-World Data of Cladribine Tablets in Patients with Multiple Sclerosis in Turkey
    Koseoglu, Mesrure
    Omerhoca, Sami
    Balci, Fatma Belgin
    Unal, Aysun
    Ozdemir, Zeynep
    Yuksel, Burcu
    Celik, Rabia Gokcen Gozubatik
    Toprak, Ufuk Emre
    Gursoy, Esra Azize
    Icen, Nilufer Kale
    Altunrende, Burcu
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1017 - 1017
  • [4] Real-world outcomes of siponimod in multiple sclerosis patients
    Tan, Hongmei
    Quan, Chao
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 1129 - 1129
  • [5] Real-world use of ofatumumab to treat multiple sclerosis 9 months post-FDA approval during COVID-19 pandemic
    Coyle, Patricia K.
    Gorritz, Magdaliz
    Wade, Rolin L.
    Zhou, Zifan
    Khalid, Subhan
    Maiese, Eric M.
    Deshpande, Chinmay
    Shao, Qiujun Samantha
    [J]. MULTIPLE SCLEROSIS AND RELATED DISORDERS, 2023, 78
  • [6] Real-world performance of alemtuzumab in multiple sclerosis patients in Chile
    Reyes, Ana
    Ciampi, Ethel
    Uribe San Martin, Reinaldo
    Carcamo, Claudia
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2019, 25 (01) : 142 - 143
  • [7] Real-World Effectiveness of Natalizumab in Korean Patients With Multiple Sclerosis
    Kim, Ki Hoon
    Kim, Su-Hyun
    Park, Na Young
    Hyun, Jae-Won
    Kim, Ho Jin
    [J]. FRONTIERS IN NEUROLOGY, 2021, 12
  • [8] Real-world effectiveness of fingolimod in patients with multiple sclerosis in Bulgaria
    Milanov, Ivan
    Ivanova, Sonya
    Tournev, Ivailo
    Chamova, Teodora
    Kaprelyan, Ara
    Slavov, Georgi
    Chervenkov, Vitan
    Kipriyanovska, Katerina
    [J]. REVISTA DE NEUROLOGIA, 2023, 77 : S1 - S7
  • [9] Characterizing up to 2 years of ofatumumab onboarding and utilization among real-world relapsing multiple sclerosis patients in Australia the EAFToS Secondary Use of Data Study
    van der Walt, Anneke
    Broadley, Simon
    Burton, Jason
    Hardy, Todd
    Kemp, Clare
    Walker, Rob
    Berry, Patricia
    Martel, Kate
    Lam, Lien
    Nelson, Morag
    [J]. MULTIPLE SCLEROSIS JOURNAL, 2023, 29 : 641 - 642
  • [10] Harnessing real-world data to inform treatment decisions in multiple sclerosis
    Hersh, Carrie M.
    Marrie, Ruth Ann
    [J]. NEUROLOGY, 2019, 93 (07) : 285 - 286
12345